Introduction--ADHD comorbidity and treatment outcomes in the MTA.
@article{Jensen2001IntroductionADHDCA, title={Introduction--ADHD comorbidity and treatment outcomes in the MTA.}, author={P. Jensen}, journal={Journal of the American Academy of Child and Adolescent Psychiatry}, year={2001}, volume={40 2}, pages={ 134-6 } }
This Special Section constitutes an important expansion ofthe first reports of the results of the NIMH CollaborativeMultisite Multimodal Treatment Study of Children WithAttention-Deficit/Hyperactivity Disorder (MTA) (MTACooperative Group, 1999a,b). In the MTA, 579 childrenwith ADHD-combined type were assigned to 14 monthsof medication management (titration followed bymonthly visits); intensive behavioral treatment (parent,school, and child components, with therapist involvementreduced over time… CONTINUE READING
Topics from this paper
40 Citations
Psychosocial Treatments for Children with Attention Deficit/Hyperactivity Disorder
- Psychology, Medicine
- Neuropsychology Review
- 2006
- 106
Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA)
- Medicine, Psychology
- Journal of attention disorders
- 2008
- 73
Science, Ethics, and the Psychosocial Treatment of ADHD
- Medicine, Psychology
- Journal of attention disorders
- 2006
- 19
Clinical Response to Methylphenidate in Children Diagnosed with Attention-Deficit Hyperactivity Disorder and Comorbid Psychiatric Disorders
- Psychology, Medicine
- Canadian journal of psychiatry. Revue canadienne de psychiatrie
- 2010
- 40
- Highly Influenced
Evaluation of the Duration of Action and Comparative Effectiveness of Lisdexamfetamine Dimesylate and Behavioral Treatment in Youth With ADHD in a Quasi-Naturalistic Setting
- Psychology, Medicine
- Journal of attention disorders
- 2015
- 5
ADHD and Psychiatric Comorbidity: Functional Outcomes in a School-Based Sample of Children
- Psychology, Medicine
- Journal of attention disorders
- 2015
- 46
Comorbidity and Child Psychopathology: Recommendations for the Next Decade
- Psychology, Medicine
- Journal of abnormal child psychology
- 2003
- 72
References
SHOWING 1-9 OF 9 REFERENCES
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 875
- PDF
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 264
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
- Medicine, Psychology
- Archives of general psychiatry
- 1999
- 2,853
- PDF
NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 1995
- 283
Fact versus Fancy concerning the Multimodal Treatment Study for Attention-Deficit Hyperactivity Disorder
- Medicine
- Canadian journal of psychiatry. Revue canadienne de psychiatrie
- 1999
- 37
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 258
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 150
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.
- Medicine, Psychology
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 829
Symptom profiles in children with ADHD: effects of comorbidity and gender.
- Psychology, Medicine
- Journal of the American Academy of Child and Adolescent Psychiatry
- 2001
- 382